Therefore, we conducted the comprehensive meta-analysis on all eligible studies to clarify these and assess the clinical value of DCLK1 in cancer diagnosis and prognosis, thereby providing more evidence for clinical practice and accelerating further investigations. The gene discussed is DCLK1; the disease is cancer.